ESR1 and breast carcinoma: Furthermore, breast cancer cells transiently over-expressing HSD17B14 significantly lowered oestradiol levels compared to mock-transfected cells, suggesting a protective role of this enzyme in which 17βHSD14 may act by lowering intra-tumoural levels of oestradiol available for oestrogen receptor (ER) binding.